Literature DB >> 10422805

Tissue-specific methylation differences in a fragile X premutation carrier.

F Tassone1, J Longshore, J Zunich, P Steinbach, U Salat, A K Taylor.   

Abstract

Methylation of a premutation was found in a small percentage of blood cells in a male premutation carrier for the FMR1 mutation. To investigate the inter-tissue heterogeneity and possible clinical implications of this finding, fibroblast cells from the subject were also studied. Although the premutation size was found to be the same in leukocytes and fibroblasts, the methylation pattern was different. In cultured fibroblasts, the premutation was completely unmethylated, as is typical of premutations, whereas methylation of the premutation was detected in a small percentage of lymphocytes. However, the change in methylation did not affect the FMR1 protein (FMRP) expression, as immunocytochemical analysis of FMRP performed on cultured skin fibroblasts and a blood smear revealed normal levels of expression in both tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10422805     DOI: 10.1034/j.1399-0004.1999.550508.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

1.  CpG methylation modifies the genetic stability of cloned repeat sequences.

Authors:  Kerrie Nichol; Christopher E Pearson
Journal:  Genome Res       Date:  2002-08       Impact factor: 9.043

Review 2.  Advances in the Understanding of the Gabaergic Neurobiology of FMR1 Expanded Alleles Leading to Targeted Treatments for Fragile X Spectrum Disorder.

Authors:  Reymundo Lozano; Veronica Martinez-Cerdeno; Randi J Hagerman
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

3.  FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.

Authors:  Lorena Santa María; Solange Aliaga; Víctor Faundes; Paulina Morales; Ángela Pugin; Bianca Curotto; Paula Soto; M Ignacia Peña; Isabel Salas; M Angélica Alliende
Journal:  Genet Res (Camb)       Date:  2016-06-28       Impact factor: 1.588

4.  The Autism Spectrum Disorders Stem Cell Resource at Children's Hospital of Orange County: Implications for Disease Modeling and Drug Discovery.

Authors:  David J Brick; Hubert E Nethercott; Samantha Montesano; Maria G Banuelos; Alexander E Stover; Soleil Sun Schutte; Diane K O'Dowd; Randi J Hagerman; Michele Ono; David R Hessl; Flora Tassone; Philip H Schwartz
Journal:  Stem Cells Transl Med       Date:  2014-10-01       Impact factor: 6.940

5.  Size and methylation mosaicism in males with Fragile X syndrome.

Authors:  Poonnada Jiraanont; Madhur Kumar; Hiu-Tung Tang; Glenda Espinal; Paul J Hagerman; Randi J Hagerman; Nuanchan Chutabhakdikul; Flora Tassone
Journal:  Expert Rev Mol Diagn       Date:  2017-11       Impact factor: 5.225

6.  CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.

Authors:  Dalyir I Pretto; Guadalupe Mendoza-Morales; Joyce Lo; Ru Cao; Andrew Hadd; Gary J Latham; Blythe Durbin-Johnson; Randi Hagerman; Flora Tassone
Journal:  J Med Genet       Date:  2014-03-03       Impact factor: 6.318

7.  Clinical and molecular implications of mosaicism in FMR1 full mutations.

Authors:  Dalyir Pretto; Carolyn M Yrigollen; Hiu-Tung Tang; John Williamson; Glenda Espinal; Chris K Iwahashi; Blythe Durbin-Johnson; Randi J Hagerman; Paul J Hagerman; Flora Tassone
Journal:  Front Genet       Date:  2014-09-17       Impact factor: 4.599

8.  FXS-Like Phenotype in Two Unrelated Patients Carrying a Methylated Premutation of the FMR1 Gene.

Authors:  Esperanza Fernández; Elena Gennaro; Filomena Pirozzi; Chiara Baldo; Francesca Forzano; Licia Turolla; Francesca Faravelli; Denise Gastaldo; Domenico Coviello; Marina Grasso; Claudia Bagni
Journal:  Front Genet       Date:  2018-11-02       Impact factor: 4.599

9.  Urine-Derived Epithelial Cell Lines: A New Tool to Model Fragile X Syndrome (FXS).

Authors:  Marwa Zafarullah; Mittal Jasoliya; Flora Tassone
Journal:  Cells       Date:  2020-10-05       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.